Leadership

Curogen’s Leadership is consisted with professional executive members with biotechnology and pharmaceutical backgrounds, collective experience, and broad visions for the future. Each one of our members leads us to broadening and developing our pipeline, and paves Curogen’s way into contributing to humanity’s health.

CEO

Chang-Woo Lee, Ph.D. CEO

Chang-Woo Lee, Ph.D.
CEO

  • · Harvard Medical School, Post-doctor
  • · Univ of Glasgow/NIMR, PhD
  • · Sungkyunkwan University School of Medicine, Professor
  • · Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Professor
  • · Ministry of Health and Welfare, Ministry of Trade, Industry and Energy, Ministry of Science and Technology: Advisory committee, Steering committee, Expert committee
  • · Invited talk at Harvard Medical school, Mayo Clinic, Oxford Univ, etc
  • · 2004~2022, Average SCI IF 16.036 for 20 selected journal publications as corresponding author

Executive Team

  • Jinkwan Lee

    Jinkwan Lee

    Chief of R&D Division

    Sungkyunkwan University School of Medicine, PhD

    Sungkyunkwan University Biomedical Research Center

  • Hyun-Soo Kim

    Hyun-Soo Kim

    Chief Strategy Officer

    Sungkyunkwan University School of Medicine, PhD

    Samsung Biomedical Research Institute

  • Myungsoon Yang

    Myungsoon Yang

    Chief Business Development Officer

    Ajou University, PhD

    5T International Patent Law Firm

    Emory University

  • Junsoo Kim

    Junsoo Kim

    Head of Medicine Development

    Korea University, PhD

    Samsung BioLogics Co.,Ltd

Board of Directors

  • Hyunsoo Kim

    Attorney at Law/Audit

    Sungkyunkwan University, Law School

    Hanhwa, Attorney at Law

  • Heounjeong Go

    University of Ulsan College of Medicine, Asan Medical Center, Department of Pathology, Professor

    Seoul National University, School of Medicine, MD/PhD

    Seoul National University Hospital, Department of Pathology, Resident and Fellow Doctor

  • Jaeyeol An

    Partners Investment, Managing Director

    Seoul National University, MSc

    Genexine Inc., Project Manager

    Samsung Medical Center, Researcher

  • Sungjune Hong

    Genexine Inc., EVP & CFO

    Yonsei University, MBA

    Vanderbilt Law School, LLM

    KICPA/AICPA/ New York Bar Member

    Daewoo Motors, Finance Manager

    Philip Morris, Finance Manager

    Nike Korea, CFO

    Handok, CFO

    Rokit Healthcare, President & COO

Scientific Advisory Board

Clinical Studies

  • Mi-La Cho, PhD

    The Catholic University of Korea, College of Medicine, Department of Medical Life Science, professor

    Autoimmune Disease

  • Sung-Hwan Park, MD/PhD

    The Catholic University of Korea Seoul St. Mary's Hospital, Division of Rheumatology, Professor

    Autoimmune Disease, Rheumatology

  • ChangMin Kim, MD/PhD

    Korean Association for the Study of the Liver, Past President

    NASH(NonAlcoholic SteatoHepatitis)/HCC(HepatoCellular Carcinoma)

  • Heounjeong Go, MD/PhD

    Professor, University of Ulsan College of Medicine, Asan Medical Center, Department of Pathology

    Clinical Pathology

Preclinical Studies

  • Yoon Jeon, PhD

    National Cancer Center, Research Core Center, Laboratory Animal Research Facility, Researcher

    Preclinical Animal Models

  • Ho Lee, PhD

    National Cancer Center, Graduate School of Cancer Science and Policy, Professor

    Preclinical Animal Models

  • Kyunghoon Lee, MD/PhD

    Sungkyunkwan University, School of Medicine, Department of Anatomy & Cell Biology, Professor

    Anatomy Pathology, Neuroscience

Scientific Studies

  • Sang-Gu Hwang, PhD

    Korea Institute of Radiological & Medical Sciences, Division of Radiation Cancer Biology, Principal Investigater

    Biochemistry, Molecular Biology, Radiobiology

  • Myong-Joon Hahn, MD/PhD

    Sungkyunkwan University, School of Medicine, Department of Molecular Cell Biology, Professor

    Molecular Medicine

  • Hyung-Ho Ha, PhD

    Sunchon National University, College of Pharmacy, Professor

    Medicinal Chemistry

  • Kyeong Sook Choi, PhD

    Ajou University, School of Medicine, Department of Biochemistry & Molecular Biology, Professor

    Molecular Medicine, tumor biology

  • Hyeseong Cho, PhD

    Ajou University, School of Medicine, Department of Biochemistry & Molecular Biology, Professor Emeritus

    Molecular Medicine

  • Hyun-Soo Cho, PhD

    Yonsei University, Department of Systems Biology, Professor

    Therapeutic Proteins

  • Jang-Soo Chun, PhD

    Gwangju Institute of Science and Technololgy, School of Life Sciences, Professor

    Degenerative Disease

  • Hyun-Ju Park, PhD

    Sungkyunkwan University, School of Pharmacy, Professor

    Medicinal Chemistry, Computer-Aided Drug Design

  • Eunae Kim, Ph.D

    Chosun University, College of Pharmacy, Professor

    Medicinal Chemistry, Computational Chemistry

  • Myung-Hee Kwon, PhD

    Ajou University School of Medicine, Department of Microbiology, Professor

    Antibody Drugs